![Defence Therapeutics Inc](/common/images/company/CNSX_DTC.png)
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.13 | -15.4761904762 | 0.84 | 0.84 | 0.71 | 16467 | 0.82653846 | CS |
4 | -0.09 | -11.25 | 0.8 | 0.96 | 0.68 | 52169 | 0.80949019 | CS |
12 | -0.79 | -52.6666666667 | 1.5 | 1.52 | 0.68 | 43017 | 0.95693312 | CS |
26 | -1.45 | -67.1296296296 | 2.16 | 2.32 | 0.68 | 34547 | 1.21992155 | CS |
52 | -2.05 | -74.2753623188 | 2.76 | 3.04 | 0.68 | 26538 | 1.68923328 | CS |
156 | -5.57 | -88.6942675159 | 6.28 | 8.15 | 0.68 | 18454 | 2.83716452 | CS |
260 | -1.04 | -59.4285714286 | 1.75 | 8.15 | 0.68 | 18301 | 2.91568065 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.